Please Wait...

An Intelligent Approach to Risk-Based Monitoring - On Demand Webinar

How People, Process and Tools can Improve Clinical Trial Quality

Duration: 1 hour

Complete form below to view the on-demand webinar >>

Many pharmaceutical companies are excited by the promise of Risk-Based Monitoring, but are uncertain as to how to implement such an initiative. In this insightful presentation, Courtney McBean will discuss the core principles of Risk-Based Monitoring and the key steps to Implementing an RBM program that goes beyond reducing site visits and instills a greater focus on quality in clinical trials.

The presentation will focus on the important role played by

  • People – Having the right people involved in your program is a must!
  • Process – Defining a repeatable plan is crucial – learn the 7 points that must be considered
  • Tools – Attendees will see firsthand how the right technology can help you monitor what matters, when it matters.

This is a must-see for any sponsor or CRO seeking to reduce costs, improve quality, and run more efficient clinical trials.

Courtney McBean is the Vice President of Clinical Innovation at BioClinica. She was a founder of Blueprint Clinical – the innovative company that created the Compass Intelligent Monitoring solution and was recognized by Gartner as a "2014 Cool Vendor in Life Sciences." Since BioClinica's May acquisition of Blueprint, Courtney and her team have doubled their efforts to challenge the pharmaceutical community to go beyond risk-based monitoring and embrace an Intelligent Monitoring approach to clinical trials that goes beyond reducing site monitoring visits to a focus on overall quality.

View all upcoming BioClinica webinars.

 

Please fill out the form below to view the On Demand Webinar.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

[Fun Friday] Now that's using you noodle! Ck this out in @RandDMagazine https://t.co/o5h9O1ScBF
bioclinica (7 hours ago)
FDA, NIH & Industry Advance Templates for Clinical Trial Protocols | RAPS https://t.co/Cqda7fLQZf
bioclinica (Yesterday)
Significant Safety Events Found in a Third of FDA-Approved Drugs, Study Finds | RAPS https://t.co/mAHe42W4or
bioclinica (Yesterday)
FDA Official Highlights Foreign Supply Chain Challenges | RAPS https://t.co/qHDtoRw9MS
bioclinica (Yesterday)
RT @MySCRS: Survey finds 50% of Americans are unaware of #ClinicalTrials, reported by @EdClinical. https://t.co/57x8gtXRT0
bioclinica (Yesterday)
RT @ACROhealth: Recent poll data from @ResearchAmerica, 59% of those polled said their family’s health has been improved by clinical resear…
bioclinica (Yesterday)

Latest Blogs: